(Q34467270)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

title

Dendritic cell regulation of NK-cell responses involves lymphotoxin-α, IL-12, and TGF-β (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

1 reference

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Marzia Palma

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Yumeng Mao

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Andreas Lundqvist

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

author name string

Lars Adamson

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Rolf Kiessling

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Håkan Mellstedt

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

Anders Österborg

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

language of work or name

English

0 references

publication date

17 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

European Journal of Immunology

3 March 2020

published in

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

volume

45

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

3 March 2020

page(s)

1783-1793

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25773885%20AND%20SRC:MED&resulttype=core&format=json

Cancer immunotherapy via dendritic cells

3 March 2020

cites work

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Current status and future perspectives of dendritic cell-based cancer immunotherapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Booster vaccinations against cancer are critical in prophylactic but detrimental in therapeutic settings

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Antigen-bearing dendritic cells regulate the diverse pattern of memory CD8 T-cell development in different tissues

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

IL-12p70-producing patient DC vaccine elicits Tc1-polarized immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Human dendritic cells activate resting natural killer (NK) cells and are recognized via the NKp30 receptor by activated NK cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

IL-18-primed helper NK cells collaborate with dendritic cells to promote recruitment of effector CD8+ T cells to the tumor microenvironment

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Toll-like receptor-dependent IL-12 production by dendritic cells is required for activation of natural killer cell-mediated Type-1 immunity induced by Chrysanthemum coronarium L.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Combination therapy of renal cell carcinoma or breast cancer patients with dendritic cell vaccine and IL-2: results from a phase I/II trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Activin-A attenuates several human natural killer cell functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Loss of NK stimulatory capacity by plasmacytoid and monocyte-derived DC but not myeloid DC in HIV-1 infected patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Blood dendritic cells suppress NK cell function and increase the risk of leukemia relapse after hematopoietic cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

The Lymphotoxin Network: orchestrating a type I interferon response to optimize adaptive immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

A lymphotoxin-beta-specific receptor

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Dendritic cell (DC)-specific targeting reveals Stat3 as a negative regulator of DC function

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Interleukin 2 signaling involves the phosphorylation of Stat proteins

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Enhanced cancer immunotherapy using STAT3-depleted dendritic cells with high Th1-inducing ability and resistance to cancer cell-derived inhibitory factors

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Inflammation-restraining effects of prostaglandin E2 on natural killer-dendritic cell (NK-DC) interaction are imprinted during DC maturation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

IL-18-induced CD83+CCR7+ NK helper cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Requirement for membrane lymphotoxin in natural killer cell development.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Regulation of T(H)2 development by CXCR5+ dendritic cells and lymphotoxin-expressing B cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Surface lymphotoxin alpha/beta complex is required for the development of peripheral lymphoid organs

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Transforming growth factor-beta regulation of immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

IL-2-dependent tuning of NK cell sensitivity for target cells is controlled by regulatory T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Reciprocal activating interaction between natural killer cells and dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Dendritic cells and natural killer cells interact via multiple TNF family molecules.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Pilot clinical trial of type 1 dendritic cells loaded with autologous tumor lysates combined with GM-CSF, pegylated IFN, and cyclophosphamide for metastatic cancer patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Targeted therapeutic remodeling of the tumor microenvironment improves an HER-2 DNA vaccine and prevents recurrence in a murine breast cancer model

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Generation of a dendritic cell-based vaccine in chronic lymphocytic leukaemia using CliniMACS platform for large-scale production.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Analysis of CD16+CD56dim NK cells from CLL patients: evidence supporting a therapeutic strategy with optimized anti-CD20 monoclonal antibodies

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

7 January 2021

NK cell activation by dendritic cell vaccine: a mechanism of action for clinical activity

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

7 January 2021

Activin A as a mediator of NK-dendritic cell functional interactions

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

7 January 2021

Interleukin-2-induces development of denditric cells from cord blood CD34+ cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

7 January 2021

The role of interleukin-2 during homeostasis and activation of the immune system

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

7 January 2021

Cellular and molecular mechanisms of IFN-γ production induced by IL-2 and IL-12 in a human NK cell line

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

7 January 2021

Interferon-gamma produced by interleukin-12-activated tumor infiltrating CD8+T cells directly induces apoptosis of mouse hepatocellular carcinoma

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

7 January 2021

IL-12 Synergizes with IL-2 to Induce Lymphokine-Activated Cytotoxicity and Perforin and Granzyme Gene Expression in Fresh Human NK Cells

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

7 January 2021

Decreased expression of NKG2D, NKp46, DNAM-1 receptors, and intracellular perforin and STAT-1 effector molecules in NK cells and their dim and bright subsets in metastatic melanoma patients

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

7 January 2021

Vaccination with dendritic cells loaded with tumor apoptotic bodies (Apo-DC) in patients with chronic lymphocytic leukemia: effects of various adjuvants and definition of immune response criteria

1 reference

https://api.crossref.org/works/10.1002%2FEJI.201444885

7 January 2021